Tirzipatide First month

Tirzepatide, during the initial month of treatment, is administered at a dosage of 2.5mg/25U once a week.

Typically, this medication is prescribed to individuals who have not responded well to semaglutide. Tirzepatide is designated for individuals between the ages of 18 and 100, contingent on consultation with a qualified healthcare practitioner.

It is vital to emphasize that this medication can solely be obtained with a valid prescription.

Under no circumstances should this product be mixed with other weight management products or have its dosage adjusted independently.

During the usage of this medication, the consumption of alcohol is discouraged to facilitate the achievement of the desired therapeutic goals while minimizing additional side effects. Adequate hydration is advised to prevent adverse effects. Should you experience side effects that interfere with your daily routine, we recommend immediate contact with our medical team.

Proper storage of this product necessitates refrigeration.